F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 102,765 shares at $22.73 ($2.4M) on 2022-10-19, disclosed to the SEC on 2022-10-20.
Open-market sale of $2.4M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.02 | 25,428 | $611K | 25.4% |
| 2 | $24.02 | 25,428 | $611K | 25.4% |
| 3 | $22.73 | 25,647 | $583K | 24.3% |
| 4 | $22.73 | 25,647 | $583K | 24.3% |
| 5 | $23.50 | 615 | $14K | 0.6% |
| Total | $23.37 avg | 102,765 |
| $2.4M |
| 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |